Inflammatory Response: Clinical Trials

4 trials for Inflammatory Response, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 21Completed 1

Follow Inflammatory Response: new trials by email Literature Review of Inflammatory Response trials Research Report on Inflammatory Response

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Inhibition of Sterile Inflammation by Digoxin
Digoxin, Placebo - Inflammatory Response
Phase 1CompletedYale University452021-03-012024-07-12
A Study to Investigate the Effects of RIST4721 on the Inflammatory Response in Healthy Male Subjects Using a Blister Model
RIST4721, Placebo - Inflammatory Response
Phase 1CompletedAristea Therapeutics, Inc.322019-07-252020-06-29
Effects of Metformin in a Non-Diabetic Patient Population
MetFORMIN Hydrochloride ER, Placebo - Inflammatory Response
Phase 1 / Phase 2CompletedBrian Zuckerbraun322019-01-222023-01-11
Influence of Dietary Nitrate on Skin Inflammation
Nitrate-rich Beetroot Juice, Nitrate-deplete Beetroot Juice - Cardiovascular Diseases, Inflammation
Phase 1CompletedQueen Mary University of London242017-02-022022-09-27

Narrower conditions

Cardiovascular Diseases (1)  ·  Dermatitis (1)  ·  Inflammation (1)  ·  Thrombosis (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Embolism and Thrombosis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Vascular Diseases (1)

Interventions

Digoxin (1)  ·  Metformin (1)

Sponsors

Aristea Therapeutics, Inc. (1)  ·  Brian Zuckerbraun (1)  ·  Queen Mary University of London (1)  ·  Yale University (1)

Countries

United Kingdom (2)  ·  United States (2)

Top investigators

Brian Zuckerbraun, MD (1)  ·  Prof Amrita Ahluwalia, BSc PhD (1)  ·  Wajahat Mehal, MD (1)

Results publications

PMID 40209616

NIH funding

U01AA026962 (1)